Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GRTS
12226
PUT
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $34.7K | ﹤0.01% |
59,800
-39,300
| -40% | -$22K |
2021 Q1
14 quarters
|
|
12227
Digital Turbine
APPS
$1.28B
| $34.7K | ﹤0.01% |
11,289
-258,431
| -96% | -$697K |
2018 Q1
26 quarters
|
|
|
SOHU
12228
PUT
Sohu.com
SOHU
$327M
| $34.6K | ﹤0.01% |
2,200
-100
| -4% | -$1.5K |
2013 Q2
45 quarters
|
|
12229
Envela
ELA
$315M
| $34.6K | ﹤0.01% |
6,320
-3,824
| -38% | -$19.3K |
2024 Q2
1 quarter
|
|
|
RVPH
12230
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $34.6K | ﹤0.01% |
1,200
-875
| -42% | -$19.4K |
2022 Q3
8 quarters
|
|
|
USBC
12231
USBC Inc
USBC
$213M
| $34.5K | ﹤0.01% |
3,010
+2,168
| +257% | +$28.4K |
2023 Q4
3 quarters
|
|
12232
PUT
J&J Snack Foods
JJSF
$1.48B
| $34.4K | ﹤0.01% |
200
-800
| -80% | -$134K |
2022 Q4
7 quarters
|
|
12233
Radiant Logistics
RLGT
$437M
| $34.4K | ﹤0.01% |
5,352
-3,746
| -41% | -$22.8K |
2023 Q3
4 quarters
|
|
|
NXDT
12234
PUT
NexPoint Diversified Real Estate Trust
NXDT
$275M
| $34.4K | ﹤0.01% |
5,500
+1,400
| +34% | +$8.31K |
2024 Q2
1 quarter
|
|
12235
CALL
DiaMedica Therapeutics
DMAC
$438M
| $34.4K | ﹤0.01% |
8,200
+6,900
| +531% | +$25.5K |
2022 Q4
7 quarters
|
|
12236
PUT
MediWound
MDWD
$170M
| $34.3K | ﹤0.01% |
1,900
-21,000
| -92% | -$383K |
2024 Q1
2 quarters
|
|
12237
PUT
ProShares UltraShort Silver
ZSL
$71.8M
| $34.3K | ﹤0.01% |
90
+22
| +32% | +$9.63K |
2022 Q4
7 quarters
|
|
12238
PUT
Inspired Entertainment
INSE
$105M
| $34.3K | ﹤0.01% |
3,700
-5,800
| -61% | -$51.4K |
2022 Q4
7 quarters
|
|
12239
PUT
Banco Santander
SAN
$203B
| $34.2K | ﹤0.01% |
6,700
-14,100
| -68% | -$67.8K |
2016 Q2
33 quarters
|
|
|
BHAT
12240
DELISTED
Blue Hat Interactive Entertainment Technology
BHAT
| $34.2K | ﹤0.01% |
+20
| New | +$67K |
2024 Q3
0 quarters
|
|
|
BRNS
12241
DELISTED
Barinthus Biotherapeutics
BRNS
| $34.1K | ﹤0.01% |
27,717
+11,680
| +73% | +$15.7K |
2024 Q2
1 quarter
|
|
|
HTB
12242
PUT
HomeTrust Bancshares
HTB
$768M
| $34.1K | ﹤0.01% |
+1,000
| New | +$33.7K |
2024 Q3
0 quarters
|
|
12243
CALL
Ennis
EBF
$571M
| $34K | ﹤0.01% |
1,400
+100
| +8% | +$2.31K |
2023 Q2
5 quarters
|
|
12244
PUT
Star Group
SGU
$425M
| $34K | ﹤0.01% |
2,900
-1,400
| -33% | -$15.9K |
2023 Q4
3 quarters
|
|
12245
CALL
Lesaka Technologies
LSAK
$401M
| $34K | ﹤0.01% |
6,800
+4,700
| +224% | +$22.3K |
2023 Q3
4 quarters
|
|
12246
CALL
BlackRock TCP Capital
TCPC
$335M
| $34K | ﹤0.01% |
4,100
-6,600
| -62% | -$63.4K |
2022 Q1
10 quarters
|
|
|
KZIA
12247
CALL
Kazia Therapeutics
KZIA
$144M
| $33.9K | ﹤0.01% |
1,576
+1,096
| +228% | +$21.9K |
2024 Q2
1 quarter
|
|
12248
CALL
iShares S&P India Nifty 50 Index Fund
INDY
$496M
| $33.8K | ﹤0.01% |
600
-1,200
| -67% | -$65.6K |
2023 Q4
3 quarters
|
|
12249
PUT
Gevo
GEVO
$316M
| $33.7K | ﹤0.01% |
20,700
-2,700
| -12% | -$2.19K |
2021 Q1
14 quarters
|
|
|
GLDD
12250
PUT
DELISTED
Great Lakes Dredge & Dock
GLDD
| $33.7K | ﹤0.01% |
3,200
-6,100
| -66% | -$56.7K |
2022 Q4
7 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.